https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/?page=17

Filter by:

Biomedical Research Centre news

A selection of images from the 2nd annual NIHR GOSH BRC competition

Fourth Annual NIHR GOSH BRC Image Competition - A Moment of Discovery

11 Nov 2024, 11 a.m.

The Research and Innovation Communications team at GOSH and the NIHR GOSH Biomedical Research team invite you to enter our Research and Innovation Showcase: A Moment of Discovery.

Female clinician sat at desk in clinic room smiling and looking towards patient. Computer screen in background.

GOSH pilots AI tool to give clinicians more quality-time with patients

11 Nov 2024, 7 a.m.

Patients and clinicians at GOSH have been taking part in the first NHS trial of a bespoke healthcare AI assistant, TORTUS, to help increase face-to-face time during appointments.

Grace at Great Ormond Street Hospital, in a wheelchair with a tablet on her lap. She's in a dress and wearing glasses.

New hope to prevent blindness in children with rare genetic disease

5 Nov 2024, 5:59 p.m.

A new treatment that could prevent blindness in children with the CLN2 type Batten disease has been trialled by Clinicians at GOSH and University College London Great Ormond Street Institute of Child Health (UCL GOS ICH).

$collection of wrist x-ray images and an AI tool highlighting in red which x-rays contain fractures$

GOSH only hospital outside of North America to receive innovation funding award for AI

31 Oct 2024, 11:52 a.m.

GOSH has been awarded the Amazon Web Services IMAGINE Grant: Children’s Health Innovation Award, to support artificial intelligence (AI) development and drive progress for children’s healthcare.

Close up shot of Frank playing in a playground

New clinical trial at GOSH gives hope to children with aggressive blood cancer

14 Oct 2024, 3 p.m.

Researchers at GOSH and UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) are collaborating on a novel approach to clinical trials to give hope to children with an aggressive type of blood cancer, T-cell acute lymphoblastic leukaemia (T-ALL)